Differences

This shows you the differences between two versions of the page.

--- pgxp [2024/11/04 11:07] – trynke
+++ pgxp [2025/08/12 14:40] (current) – petra_vinke
@@ Line 14: / Line 14: @@
   - **uptake** in terms of (a) installing the application, (b) giving consent to receiving the PGx passport, (c) reading the information provided, and (d) sharing the information provided with their own healthcare professionals (when appropriate)?
-Potential determinants are sociodemographic characteristics, health status and use of medication, health literacy, perceived barriers, facilitators, and benefits of sharing the PGx passport.
+Sociodemographic characteristics, health status and use of medication, health literacy, perceived barriers, facilitators, and benefits of sharing the PGx passport were taken into account as potential determinants.
 ===== Protocol =====
@@ Line 23: / Line 23: @@
   * A total of n=~620 participants completed all the steps and received their personal information in the app.\\
   * As a final step, all ~1150 respondents to the baseline PGxP questionnaire received a follow-up questionnaire containing questions on their decision-making process, opinion on the shared information and on the app, and the actual use of the PGxP (if applicable).
+===== Publications =====
+The following publication was based on the PGXP Assessment:
+  * Lanting et al. (2025) [[https://www.cell.com/ajhg/abstract/S0002-9297(25)00102-8|Low-cost generation of clinical-grade, layperson-friendly pharmacogenetic passports using oligonucleotide arrays]]. AJHG 112(5): P1015-1028